Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Hetero
1x10 Tablets
Bicalutamide
Keep in cold place
Delivering To:
Overview
Bicatero 50mg tablet is an anti-cancer drug that works by blocking the effect of the natural male hormones (testosterone) on the growth of prostate cells. This stops the tumor from growing and spreading and also leads to the reduction of its size. Bicatero 50mg tablet is also used in combination therapy with radiotherapy or prostate surgery in the early stages of the treatment. It should be taken at a fixed time every day with or without food.
Prostate Cancer
Treatment of Prostate cancer
Most side effects caused by the Bicatero 50mg tablet don't require medical attention and may vanish upon your adjustment to the medicine. Consult your doctor immediately if you're unable to deal with these symptoms or if they persist. Decreased appetite
Dizziness Nocturia (increased urge to urinate during the night)
Edema (swelling)
Anemia (low number of red blood cells)
Rash
Hot flashes
Nausea
Weaknes Abdominal pain
Constipation
Take the Bicatero 50mg tablet as prescribed by your health professional. Ensure you take this cancer-fighting formulation in the same amount as directed by your physician. In case of an overdose, the patient is advised to consult a general practitioner as soon as possible if any unusual symptoms occur. Bicatero 50mg tablet should be swallowed as a whole. Let your doctor know if you have liver, thyroid, kidney disease, etc, or are on some other medications. Bicatero 50mg tablet is not recommended for pregnant and breastfeeding women.
Bicatero 50mg tablet functions by decreasing the effect of testosterone (male hormone) in the body. It does this by blocking the action of testosterone at specific sites, which slows down or prevents hormone-related changes in the human body. As a result, certain cells or tissues may be affected.
Alcohol
unsafe
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Bicatero 50mg Tablet. Consult your doctor for further information.
Pregnancy
consult your doctor
Bicatero 50mg Tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition. According to some research data, taking Bicatero 50mg Tablet during pregnancy has shown harmful effects on the developing baby.
Breast Feeding
consult your doctor
Bicatero 50mg Tablet is probably not safe if you're breastfeeding. Kindly consult your doctor before taking Bicatero 50mg Tablet while breastfeeding, as there are chances that it may pass to the developing baby through the breast milk of the mother.
Driving
danger
It is advisable not to drive or operate heavy machinery after taking Bicatero 50mg Tablet, as you may feel dizzy.
Kidney
caution
Share your medical history with your healthcare expert in case of kidney disease before taking Bicatero 50mg Tablet. Patients with renal impairment must be careful while taking Bicatero 50mg Tablet. They may require adjustment in the dose.
Liver
caution
Inform your doctor before starting Bicatero 50mg Tablet if you have liver disease to avoid any serious side effects. Patients with hepatic impairment must be careful while taking Bicatero 50mg Tablet. They may require adjustment in the dose.
It is advisable to avoid missing any dose of Bicalutamide 50mg however in case you missed a dose consult your doctor immediately.
Prostate cancer is treated with Bicatero 50mg tablet.
An anticancer drug, Bicatero 50mg tablet contains Bicalutamide, which works by inhibiting the effects of androgens such as testosterone and reduces or prevents the growth of prostate cancer cells and eventually shrinks the prostate tumour.
It is advised not to take alcohol while taking the Bicatero 50mg tablet because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.
As soon as you remember, take the missed dose. unless it's time for your next dose. You should never take a double dose to make up for a missed one.
Please ask your doctor if you face this issue, as it may be linked to a lung problem.
Bicatero 50mg tablet can pass through the mother's blood and harm the unborn baby. So, it is advised not to give this drug to pregnant and breastfeeding women.
A balanced diet is advised while taking the Bicatero 50mg tablet. You should drink plenty of water and avoid consuming excessive amounts of sugar or salty food. Intake of alcohol should be avoided.
Your doctor may advise you to undergo certain medical tests, such as liver or pancreatic, blood pressure, kidney, urine tests, complete blood tests, and other necessary tests, before starting Bicatero 50mg tablet. Breastfeeding and pregnant women should pay attention before taking the Bicatero 50mg tablet.
1. Bilusic M, Toney NJ, Donahue RN, Wroblewski S, Zibelman M, Ghatalia P, Ross EA, Karzai F, Madan RA, Dahut WL, Gulley JL, Schlom J, Plimack ER, Geynisman DM. (2023). A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate Cancer Prostatic Dis. 25(4):735-740. Epub.
2. Furr BJ, Tucker H. (2022). The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology. 1996 Jan;47(1A Suppl):13-25; discussion 29-32.
3. Furr BJ. (2025). The development of Casodex (bicalutamide): preclinical studies. Eur Urol. 1996;29 Suppl 2:83-95.
4. Kotake T, Usami M, Isaka S, Shimazaki J, Nakano E, Okuyama A, Okajima E, Kanetake H, Saitoh Y, Kumamoto Y, Orikasa S, Sakata Y, Hosaka M, Akaza H, Koiso K, Honma Y, Aso Y, Oishi K, Yoshida O, Naitoh S, Kumazawa J, Koyanagi T, Yachiku S, Shiraiwa Y, Tsukagoshi S. (2025). [Clinical early phase II study of bicalutamide (Casodex) in patients with prostatic cancer]. Hinyokika Kiyo.42(2):157-68. Japanese.
5. Lee S, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. (2024). Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects. Clin Ther. 32(14):2496-501.
6. Marijo Bilusic et al. (2023). Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1). JCO 38, 85-85(2020).
7. Qian SB, Shen HB, Cao QF, Zhang L, Chen YF, Qi J. (2025). Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer. Int Urol Nephrol. 47(3):479-84.
8. Soloway MS, Schellhammer PF, Smith JA Jr, Chodak GW, Vogelzang NJ, Kennealey GT. (2024). Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy, and long-term endocrine effects of monotherapy. J Urol. 154(6):2110-4.
9. Soloway MS, Schellhammer PF, Smith JA, Chodak GW, Kennealey GT. (2024). Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial. Urology. (1A Suppl):33-7; discussion 48-53.
Hetero
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.